PackTalk is a blog for the Healthcare Packaging Industry

Where Device and Drug Makers Come Together


Published on August 21, 2020

As industry innovators seek to master the growing injectables market, partnering across disciplines helps overcome regulatory and practical challenges.

The vial-to-syringe story in pharmaceutical packaging and delivery is well known. There is no doubt that the advent and swift advancement of safe, convenient, and versatile drug delivery systems (think pre-filled syringes to pens and on-body delivery options) is game changing. Yet, if you are a drug developer, high-tech devices and delivery systems add complexity to your job of creating a safe, effective therapeutic.

With growing demand for combination products, the device, components, packaging and regulatory filings also make way into your camp. That’s a lot. It is this space where device and drug makers are coming together. Development service providers help drug developers connect with the industry counterparts relevant to each journey—thus streamlining the path to market by ensuring expert direction every step of the way.

A recent Healthcare Packaging article unpacks the trends, standards and partnerships that are emerging as a result of the combination product market complexities. By joining with experts to tackle each major facet of development, compatibility between therapeutic, packaging and delivery device can be addressed early on, for a smooth(er) process.

Read more


Comments (0)

Related Articles

One Doctor’s Request for Sustainable Change in Asia

September 17, 2021

152 kilograms. 4500 tonnes. 134 hectares. No matter how you say it, it’s not positive or sustainable. These numbers reflect the amount of medical waste from just one surgery, in a study from four hospitals over three months in New Zealand. 152 kilograms is...

Learn More

Cracking the Age Old Dilemma: Compliance or Quality?

September 17, 2021

I recently read an article from Medtech Insights on how device giants Stryker and Baxter embrace a quality first culture – and yield positive results. In the article, Stryker’s Medha Trivedi, the company’s senior director of global quality and operations said...

Learn More

Power to the PDUFA

September 17, 2021

The Prescription Drug User Fee Act was passed into law by Congress in 1992. The PDUFA implemented a fee-based framework for New Drug Applications and Biologics License Applications. One of its primary objectives was to provide funding to speed up the glacial...

Learn More

Stay Informed

To stay up to date on innovative technology and products, as well as industry trends, subscribe to Oliver’s PackTalk blog below.